CN116997561A - 肽及含有该肽作为有效成分的组合物 - Google Patents

肽及含有该肽作为有效成分的组合物 Download PDF

Info

Publication number
CN116997561A
CN116997561A CN202280019836.9A CN202280019836A CN116997561A CN 116997561 A CN116997561 A CN 116997561A CN 202280019836 A CN202280019836 A CN 202280019836A CN 116997561 A CN116997561 A CN 116997561A
Authority
CN
China
Prior art keywords
peptide
present technology
amino acid
acid sequence
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280019836.9A
Other languages
English (en)
Chinese (zh)
Inventor
大日向耕作
藤井晖
中田创
栗本昌树
越智浩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga Milk Industry Co Ltd
Kyoto University NUC
Original Assignee
Morinaga Milk Industry Co Ltd
Kyoto University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd, Kyoto University NUC filed Critical Morinaga Milk Industry Co Ltd
Publication of CN116997561A publication Critical patent/CN116997561A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202280019836.9A 2021-03-24 2022-03-24 肽及含有该肽作为有效成分的组合物 Pending CN116997561A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021-050468 2021-03-24
JP2021050468 2021-03-24
PCT/JP2022/013912 WO2022202985A1 (ja) 2021-03-24 2022-03-24 ペプチド、及び該ペプチドを有効成分として含有する組成物

Publications (1)

Publication Number Publication Date
CN116997561A true CN116997561A (zh) 2023-11-03

Family

ID=83397360

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280019836.9A Pending CN116997561A (zh) 2021-03-24 2022-03-24 肽及含有该肽作为有效成分的组合物

Country Status (5)

Country Link
US (1) US20240158440A1 (https=)
EP (1) EP4317173A4 (https=)
JP (1) JPWO2022202985A1 (https=)
CN (1) CN116997561A (https=)
WO (1) WO2022202985A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118785917A (zh) * 2021-12-15 2024-10-15 维格治疗股份有限公司 治疗性肽的用途
WO2024259556A1 (en) * 2023-06-19 2024-12-26 Viage Therapeutics, Inc. Uses of therapeutic peptides
WO2025173704A1 (ja) * 2024-02-16 2025-08-21 エフバイタル株式会社 薬剤のスクリーニング方法、および剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4633876B2 (ja) * 1999-11-11 2011-02-16 カルピス株式会社 トリペプチドの製造方法
CA2445743A1 (en) * 2003-10-08 2005-04-08 The University Of British Columbia Methods for modulating neuronal responses
CA2784132C (en) * 2009-12-28 2015-05-05 Calpis Co., Ltd. Composition for improving brain function and method for improving brain function
HK1206761A1 (en) * 2012-03-26 2016-01-15 Axcella Health Inc. Nutritive fragments, proteins and methods
WO2015194564A1 (ja) * 2014-06-16 2015-12-23 キリン株式会社 記憶学習機能及び／又は認知機能を増強するための組成物
JP6262694B2 (ja) * 2014-08-18 2018-01-17 森永乳業株式会社 プロリルオリゴペプチダーゼ阻害剤
WO2018164019A1 (en) * 2017-03-04 2018-09-13 Kyoto University Therapeutic peptides
KR20220007584A (ko) * 2019-02-11 2022-01-18 주무토르 바이오로직스 인코포레이티드 항-clec2d 항체 및 이의 사용 방법
JP7428480B2 (ja) * 2019-06-06 2024-02-06 雪印メグミルク株式会社 睡眠改善用組成物及び組成物を含む食品、医薬品、飼料

Also Published As

Publication number Publication date
US20240158440A1 (en) 2024-05-16
WO2022202985A1 (ja) 2022-09-29
EP4317173A4 (en) 2025-03-19
EP4317173A1 (en) 2024-02-07
JPWO2022202985A1 (https=) 2022-09-29

Similar Documents

Publication Publication Date Title
JP6524176B2 (ja) プロリルオリゴペプチダーゼ阻害剤
CN116997561A (zh) 肽及含有该肽作为有效成分的组合物
JP6344796B2 (ja) 高齢者用アルツハイマー型認知症改善剤
JP6189994B2 (ja) ジペプチジルペプチダーゼ−ｉｖ阻害用飲食品組成物
JP2015084694A (ja) ジペプチジルペプチダーゼ−ｉｖ阻害剤
JP2017031105A (ja) 食後血糖値の上昇抑制を促進させる剤
JP7358239B2 (ja) エネルギー消費促進用組成物
JP6498437B2 (ja) 表皮基底膜保護剤
JP6369990B2 (ja) 筋萎縮抑制剤及び筋萎縮抑制用飲食品
JP6345630B2 (ja) 新規ペプチド及びその用途
JP2024168267A (ja) 筋萎縮抑制用組成物
JP6778094B2 (ja) カゼイン酵素分解物の製造方法及びカゼイン酵素分解物
JP6589011B2 (ja) 脳機能障害改善用経口組成物
JP2021100412A (ja) カゼイン酵素処理物及びその製造方法
JP7344722B2 (ja) 構成行為改善用組成物
JP7847653B2 (ja) 組成物
JP6964635B2 (ja) 見当識改善用組成物
WO2019160023A1 (ja) 脳卒中予防用組成物
WO2024071404A1 (ja) 新規ペプチド、及び抗酸化用組成物
JP6309367B2 (ja) カゼイン加水分解物の製造方法
JP2017048124A (ja) アミノペプチダーゼａ阻害剤
JP2024033770A (ja) 脳機能低下の予防、治療、又は軽減用組成物、及び、アミロイドβ凝集体の蓄積抑制のための組成物
JP2021024847A (ja) 脳機能障害改善用組成物
CN120569136A (zh) 抗肥胖用组合物
JP2015189672A (ja) 概日リズム改善剤

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination